Charles River Laboratories International (CRL) Gross Profit (2009 - 2025)

Charles River Laboratories International (CRL) has reported Gross Profit for 17 consecutive years, with $744.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Gross Profit rose 305.17% year-over-year to $744.9 million; the TTM figure through Dec 2025 stood at $2.2 billion (up 41.55% YoY), while the FY2025 annual figure was $3.4 billion, up 46.17% from the prior year.
• Gross Profit came in at $744.9 million for Q4 2025 at Charles River Laboratories International, up from $596.7 million in the prior quarter.
• The five-year high for Gross Profit was $1.9 billion in Q4 2021, with the low at -$363.1 million in Q4 2024.
• Average Gross Profit over 5 years is $589.4 million, with a median of $473.6 million recorded in 2022.
• Across the five-year window, Gross Profit plunged 152.25% in 2024 and jumped 305.17% in 2025, its largest moves.
• Year by year, Gross Profit stood at $1.9 billion in 2021, then slumped by 73.94% to $496.7 million in 2022, then jumped by 39.91% to $695.0 million in 2023, then tumbled by 152.25% to -$363.1 million in 2024, then surged by 305.17% to $744.9 million in 2025.
• According to Business Quant data, Gross Profit over the past three periods registered $744.9 million, $596.7 million, and $447.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.